Cancers, Vol. 15, Pages 5356: New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer & mdash;A Systematic Review
The objective is to highlight the molecular mechanisms of the most promising targeted agents under clinical investigation to demonstrate their potential relevance in recurrent/refractory OC.
Source: Cancers - Category: Cancer & Oncology Authors: Cornelia Bachmann Tags: Systematic Review Source Type: research
More News: Biology | Borderline Endometrioid Tumor | Borderline Mucinous Tumor | Borderline Serous Tumor | Borderline Tumor | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinosarcoma | Chemotherapy | Diets | Eating Disorders & Weight Management | Endometrial Cancer | Epithelial Cancer | Immunotherapy | Men | Molecular Biology | Mucinous Carcinoma | Mucinous Ovarian Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nutrition | Obesity | Ovarian Cancer | Ovaries | Serous Carcinoma | Smokers | Study
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024